A Role of the Ah Receptor in Hematopoiesis: Model Characterization
Ah 受体在造血中的作用:模型表征
基本信息
- 批准号:7763260
- 负责人:
- 金额:$ 7.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAdolescentAgeAging-Related ProcessAllelesAnimalsAromatic Polycyclic HydrocarbonsAryl Hydrocarbon ReceptorAutoimmune DiseasesBindingBlood CellsBone MarrowBone Marrow TransplantationCell CycleCell LineageCellsCharacteristicsChemical ActionsClinicalDataDevelopmentDioxinsDiseaseEquilibriumEventExhibitsExposure toFlow CytometryGenesHematopoiesisHematopoieticHematopoietic stem cellsHumanHydrocarbonsIncidenceKineticsLinkMalignant NeoplasmsMediatingModelingMusPancytopeniaPhysiologicalPlayPopulationPreventionProcessReceptor ActivationRegulationRoleSpecificityStem cellsStressTestingTransplantationaryl hydrocarbon receptor ligandcancer therapyexposed human populationgenetic regulatory proteinin vivoleukemialeukemia/lymphomamouse modelpublic health relevancereceptorreconstitutionregenerativeself-renewalstemtranscription factor
项目摘要
DESCRIPTION (provided by applicant): Human exposures to polycyclic aromtic hydrocarbons and dioxins have been linked to the development of lymphomas and leukemias. The actions of these chemicals are mediated by a gene regulatory protein, the aryl hydrocarbon receptor (AhR). Persistent AhR activation in mice results in altered numbers and function of hematopoietic stem cells (HSCs). Preliminary data from Ahr null-allele (AhR-KO) mice also provides evidence to indicate that the AhR has a physiological role in the regulation of HSCs. The overall hypothesis is that AhR dysregulation plays a role in a number of hematopoietic disorders including leukemia. In this proposal we will begin to test the specific hypothesis that the AhR has an important role in the self-renewal and proliferation of HSCs. To do this, it is necessary to further define the phenotypic and functional characteristics of HSCs in AhR-KO mice. Using this mouse model and a variety of flow cytometry approaches, we will determine if HSCs in AhR-KO mice have high proliferation rates in vivo, and will identify the specific phenotypically-defined cell populations exhibiting this characteristic. We will also define the multi-lineage developmental potential of these cells under hematopoietic stress conditions. In a second aim, we will assess by primary and serial transplantation, the ability and kinetics of HSCs from AhR-KO mice for multi-lineage reconstitution. PUBLIC HEALTH RELEVANCE: The further understanding of the processes regulating HSC self-renewal and differentiation are fundamental to the prevention and treatment of a variety of leukemias and other hematopoietic diseases in humans. Understanding what regulates the normally incredible regenerative capacity of bone marrow also has clinical implications for bone marrow transplantation, autoimmune disease, and bone marrow failure that may be associated with cancer treatment. Furthermore, these events are intimately tied with the process of aging and a variety of diseases, including cancer, whose incidence increases with age.
描述(由申请人提供):人类暴露于多环芳烃和二恶英与淋巴瘤和白血病的发展有关。这些化学物质的作用是由一种基因调控蛋白,芳烃受体(AhR)介导的。在小鼠中,持续的AhR激活导致造血干细胞(hsc)数量和功能的改变。Ahr零等位基因(Ahr - ko)小鼠的初步数据也提供了证据,表明Ahr在调节造血干细胞中具有生理作用。总体假设是AhR失调在包括白血病在内的许多造血疾病中起作用。在本提案中,我们将开始验证AhR在造血干细胞的自我更新和增殖中起重要作用的具体假设。为此,有必要进一步明确AhR-KO小鼠造血干细胞的表型和功能特征。使用该小鼠模型和各种流式细胞术方法,我们将确定AhR-KO小鼠中的hsc在体内是否具有高增殖率,并将确定表现出这种特征的特定表型定义的细胞群。我们还将定义这些细胞在造血应激条件下的多谱系发育潜力。在第二个目标中,我们将通过一次移植和系列移植来评估AhR-KO小鼠造血干细胞多系重建的能力和动力学。公共卫生相关性:进一步了解调节造血干细胞自我更新和分化的过程是预防和治疗人类各种白血病和其他造血疾病的基础。了解是什么调节了正常情况下令人难以置信的骨髓再生能力,对骨髓移植、自身免疫性疾病和可能与癌症治疗相关的骨髓衰竭也具有临床意义。此外,这些事件与衰老过程和各种疾病密切相关,包括癌症,其发病率随着年龄的增长而增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas A Gasiewicz其他文献
Thomas A Gasiewicz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas A Gasiewicz', 18)}}的其他基金
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
Ah 受体依赖性造血干细胞控制的信号通路
- 批准号:
8556514 - 财政年份:2013
- 资助金额:
$ 7.62万 - 项目类别:
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
Ah 受体依赖性造血干细胞控制的信号通路
- 批准号:
8711463 - 财政年份:2013
- 资助金额:
$ 7.62万 - 项目类别:
EGCG Has Anti-prostate Cancer Activity by Inhibiting hsp90
EGCG 通过抑制 hsp90 具有抗前列腺癌活性
- 批准号:
8189491 - 财政年份:2011
- 资助金额:
$ 7.62万 - 项目类别:
EGCG Has Anti-prostate Cancer Activity by Inhibiting hsp90
EGCG 通过抑制 hsp90 具有抗前列腺癌活性
- 批准号:
8332788 - 财政年份:2011
- 资助金额:
$ 7.62万 - 项目类别:
A Role of the Ah Receptor in Hematopoiesis: Model Characterization
Ah 受体在造血中的作用:模型表征
- 批准号:
7581310 - 财政年份:2009
- 资助金额:
$ 7.62万 - 项目类别:
An Endogenous Ah Receptor Ligand: Gene and Physiological Responses
内源性 Ah 受体配体:基因和生理反应
- 批准号:
7293745 - 财政年份:2007
- 资助金额:
$ 7.62万 - 项目类别:
An Endogenous Ah Receptor Ligand: Gene and Physiological Responses
内源性 Ah 受体配体:基因和生理反应
- 批准号:
7487558 - 财政年份:2007
- 资助金额:
$ 7.62万 - 项目类别:
EGCG Inhibits AhR and Carcinogenesis by Modulating Hsp90
EGCG 通过调节 Hsp90 抑制 AhR 和致癌作用
- 批准号:
7014379 - 财政年份:2006
- 资助金额:
$ 7.62万 - 项目类别:
相似海外基金
Enhancing Structural Competency in School-Based Health Centers to Address LGBTQ+ Adolescent Health Equity
增强校本健康中心的结构能力,以解决 LGBTQ 青少年健康公平问题
- 批准号:
10608426 - 财政年份:2023
- 资助金额:
$ 7.62万 - 项目类别:
Application and feasability of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care - a pilot study
简短的数字筛查工具的应用和可行性,以解决儿科医疗中父母和青少年烟草和电子烟的使用问题 - 一项试点研究
- 批准号:
486580 - 财政年份:2022
- 资助金额:
$ 7.62万 - 项目类别:
Studentship Programs
Co-design of an intervention to address alcohol use among adolescent boys and young men in Tanzania
共同设计一项干预措施,解决坦桑尼亚青春期男孩和年轻男性的饮酒问题
- 批准号:
MR/V032380/1 - 财政年份:2022
- 资助金额:
$ 7.62万 - 项目类别:
Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/1 - 财政年份:2021
- 资助金额:
$ 7.62万 - 项目类别:
Research Grant
Application of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care
应用简短的数字筛查工具来解决儿科医疗中父母和青少年烟草和电子烟的使用问题
- 批准号:
455984 - 财政年份:2021
- 资助金额:
$ 7.62万 - 项目类别:
Operating Grants
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/2 - 财政年份:2021
- 资助金额:
$ 7.62万 - 项目类别:
Research Grant
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10057761 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10213683 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 7.62万 - 项目类别:
Designing targeted interventions to address HIV vulnerabilities and improve clinical outcomes among conflict affected adolescent girls and young women under 25 in Northern Uganda
设计有针对性的干预措施,以解决乌干达北部受冲突影响的少女和 25 岁以下年轻妇女的艾滋病毒脆弱性并改善临床结果
- 批准号:
356145 - 财政年份:2016
- 资助金额:
$ 7.62万 - 项目类别:
Operating Grants














{{item.name}}会员




